• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝血因子和血小板对大鼠药物性肝炎和肝损伤的反应。

Blood coagulation factors and platelet response to drug-induced hepatitis and hepatosis in rats.

机构信息

Department of Structure and function of proteins, Palladin Institute of Biochemistry of NAS of Ukraine, Kyiv, Ukraine.

National University of Life and Environmental Sciences of Ukraine, Kyiv, Ukraine.

出版信息

Animal Model Exp Med. 2023 Feb;6(1):66-73. doi: 10.1002/ame2.12301. Epub 2022 Dec 27.

DOI:10.1002/ame2.12301
PMID:36574273
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9986226/
Abstract

BACKGROUND

Knowing the variability of blood coagulation responses to liver damage of different origins can provide a key to curing liver tissues or to mitigating treatment side effects. The aim of the present work was to compare the changes in the main components of hemostasis under experimental drug-induced hepatosis and hepatitis in rats.

METHODS

We modeled diclofenac-induced hepatitis and tetracycline-induced hepatosis. Hemostasis response was gauged by measuring fibrinogen, factor X, protein C (PC), and prothrombin in plasma. The decarboxylated form of prothrombin was detected by measuring prothrombin index and ecamulin index. Platelet reactivity was studied using aggregometry.

RESULTS

Both hepatitis and hepatosis decreased the synthesis of fibrinogen, factor X, and prothrombin. However, protein carboxylation was not disrupted in hepatosis but was much impaired in hepatitis. PC decreased in both models as a consequence of its consumption possibly during inflammatory response. Platelet aggregation rate was lower in hepatosis but higher in hepatitis.

CONCLUSIONS

Our findings imply the need for a thorough monitoring of the hemostasis system in liver diseases to avoid possible thrombotic complications. Its state indicates the disorder's rate and character.

摘要

背景

了解不同来源的肝损伤对凝血反应的变化差异,可为治疗肝组织或减轻治疗副作用提供关键信息。本研究旨在比较实验性药物诱导的肝炎和大鼠肝损伤时止血系统主要成分的变化。

方法

我们建立了双氯芬酸诱导的肝炎和四环素诱导的肝损伤模型。通过测量血浆中的纤维蛋白原、因子 X、蛋白 C(PC)和凝血酶原来评估止血反应。通过测量凝血酶原指数和 ecamulin 指数来检测凝血酶原的脱羧形式。使用聚集仪研究血小板反应性。

结果

肝炎和肝损伤均降低了纤维蛋白原、因子 X 和凝血酶原的合成。然而,肝损伤并未破坏蛋白的羧化作用,而肝炎则严重损害了蛋白的羧化作用。可能是由于炎症反应,两种模型中的 PC 均减少。肝损伤时血小板聚集率较低,而肝炎时则较高。

结论

我们的研究结果表明,需要对肝脏疾病中的止血系统进行全面监测,以避免可能的血栓并发症。其状态表明了疾病的速度和特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0bc/9986226/3665c34fea42/AME2-6-66-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0bc/9986226/8a9300b46556/AME2-6-66-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0bc/9986226/128c10c60349/AME2-6-66-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0bc/9986226/6a7b6f58fd40/AME2-6-66-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0bc/9986226/eba9e168f2ee/AME2-6-66-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0bc/9986226/0dc817dc7b24/AME2-6-66-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0bc/9986226/49b57f6b1e2e/AME2-6-66-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0bc/9986226/3665c34fea42/AME2-6-66-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0bc/9986226/8a9300b46556/AME2-6-66-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0bc/9986226/128c10c60349/AME2-6-66-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0bc/9986226/6a7b6f58fd40/AME2-6-66-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0bc/9986226/eba9e168f2ee/AME2-6-66-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0bc/9986226/0dc817dc7b24/AME2-6-66-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0bc/9986226/49b57f6b1e2e/AME2-6-66-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0bc/9986226/3665c34fea42/AME2-6-66-g004.jpg

相似文献

1
Blood coagulation factors and platelet response to drug-induced hepatitis and hepatosis in rats.凝血因子和血小板对大鼠药物性肝炎和肝损伤的反应。
Animal Model Exp Med. 2023 Feb;6(1):66-73. doi: 10.1002/ame2.12301. Epub 2022 Dec 27.
2
Safety of coagulation factor concentrates guided by ROTEM™-analyses in liver transplantation: results from 372 procedures.肝移植中 ROTEM 分析指导下凝血因子浓缩物的安全性:372 例手术的结果。
BMC Anesthesiol. 2019 Jun 11;19(1):97. doi: 10.1186/s12871-019-0767-x.
3
Singlet oxygen inactivates fibrinogen, factor V, factor VIII, factor X, and platelet aggregation of human blood.单线态氧可使人体血液中的纤维蛋白原、凝血因子V、凝血因子VIII、凝血因子X失活,并抑制血小板聚集。
Thromb Res. 2000 Mar 15;97(6):473-80. doi: 10.1016/s0049-3848(99)00211-x.
4
Fibrinogen interaction with human platelets: effect of other coagulation factors, prostaglandins and platelet inhibitors.纤维蛋白原与人血小板的相互作用:其他凝血因子、前列腺素和血小板抑制剂的影响。
Thromb Res. 1983 Aug 1;31(3):415-26. doi: 10.1016/0049-3848(83)90406-1.
5
Intravascular coagulation in liver disease.肝病中的血管内凝血。
Annu Rev Med. 1974;25:447-55. doi: 10.1146/annurev.me.25.020174.002311.
6
Bothrops jararaca envenomation: Pathogenesis of hemostatic disturbances and intravascular hemolysis.巴西矛头蝮蛇咬伤:止血障碍和血管内溶血的发病机制。
Exp Biol Med (Maywood). 2015 Nov;240(11):1528-36. doi: 10.1177/1535370215590818. Epub 2015 Jun 16.
7
Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count.重组活化凝血因子VII在正常及血小板计数降低情况下的流动条件下可增强血小板黏附和活化。
J Thromb Haemost. 2005 Apr;3(4):742-51. doi: 10.1111/j.1538-7836.2005.01227.x.
8
Effect of oral contraceptive use on platelet prothrombin converting (platelet factor 3) activity.口服避孕药对血小板凝血酶原转化(血小板因子3)活性的影响。
Thromb Res. 1979;15(5-6):631-8. doi: 10.1016/0049-3848(79)90173-7.
9
[Liver lesions caused by oral contraceptives. I. Contraceptive-induced hepatosis in 85 women: recommendations for diagnosis and prophylaxis].[口服避孕药所致肝脏损害。I. 85例妇女的避孕药性肝病:诊断与预防建议]
Dtsch Gesundheitsw. 1978;33(27):1251-6.
10
Liver protection and hemostatic effects of medicinal plant Arnebia euchroma (Royle) I.M.Johnst extract in a rat model.药用植物新疆紫草提取物对大鼠模型的肝脏保护及止血作用
J Ethnopharmacol. 2023 Jan 10;300:115739. doi: 10.1016/j.jep.2022.115739. Epub 2022 Sep 17.

引用本文的文献

1
Anti-Inflammatory and Antiplatelet Interactions on PAF and ADP Pathways of NSAIDs, Analgesic and Antihypertensive Drugs for Cardioprotection-In Vitro Assessment in Human Platelets.非甾体抗炎药、镇痛药及抗高血压药对血小板活化因子(PAF)和二磷酸腺苷(ADP)途径的抗炎及抗血小板相互作用——人体血小板的体外评估用于心脏保护
Medicina (Kaunas). 2025 Aug 4;61(8):1413. doi: 10.3390/medicina61081413.
2
Biomarkers of Hepatic Toxicity: An Overview.肝毒性生物标志物:概述
Curr Ther Res Clin Exp. 2024 Apr 26;100:100737. doi: 10.1016/j.curtheres.2024.100737. eCollection 2024.

本文引用的文献

1
Primary Hemostasis in Chronic Liver Disease and Cirrhosis: What Did We Learn over the Past Decade?慢性肝脏疾病和肝硬化的初级止血:过去十年我们学到了什么?
Int J Mol Sci. 2020 May 6;21(9):3294. doi: 10.3390/ijms21093294.
2
Role of Both Protein C and Antithrombin III as Predictors of Stage of Liver Disease in Chronic Viral Hepatitis B or C Infected Patients.蛋白C和抗凝血酶III作为慢性乙型或丙型病毒性肝炎感染患者肝病分期预测指标的作用
Endocr Metab Immune Disord Drug Targets. 2020;20(1):112-117. doi: 10.2174/1871530319666190529092555.
3
Comparison of clot-based and chromogenic assay for the determination of protein c activity.
基于凝血块法和发色底物法测定蛋白C活性的比较。
Blood Coagul Fibrinolysis. 2019 Jun;30(4):156-160. doi: 10.1097/MBC.0000000000000806.
4
Hemostasis, bleeding and thrombosis in liver disease.肝病中的止血、出血和血栓形成
J Transl Sci. 2017 May;3(3). doi: 10.15761/JTS.1000182. Epub 2017 Mar 4.
5
Pathogenesis, prevention, and management of bleeding and thrombosis in patients with liver diseases.肝病患者出血与血栓形成的发病机制、预防及管理
Res Pract Thromb Haemost. 2017 Aug 5;1(2):150-161. doi: 10.1002/rth2.12028. eCollection 2017 Oct.
6
Effectiveness of PIVKA-II in the detection of hepatocellular carcinoma based on real-world clinical data.基于真实世界临床数据的 PIVKA-II 在肝细胞癌检测中的有效性。
BMC Cancer. 2017 Sep 1;17(1):608. doi: 10.1186/s12885-017-3609-6.
7
PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients.异常凝血酶原是用于对肝硬化患者超声检测出的肝脏结节进行诊断特征描述的有用工具。
Medicine (Baltimore). 2017 Jun;96(26):e7266. doi: 10.1097/MD.0000000000007266.
8
Drug-induced liver injury due to antibiotics.抗生素所致药物性肝损伤
Scand J Gastroenterol. 2017 Jun-Jul;52(6-7):617-623. doi: 10.1080/00365521.2017.1291719. Epub 2017 Feb 20.
9
Genome-Wide Association Studies for Idiosyncratic Drug-Induced Hepatotoxicity: Looking Back-Looking Forward to Next-Generation Innovation.特异质性药物性肝毒性的全基因组关联研究:回顾与展望下一代创新
OMICS. 2017 Mar;21(3):123-131. doi: 10.1089/omi.2017.0006. Epub 2017 Feb 16.
10
Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.在中国,去γ-羧基凝血酶原与甲胎蛋白对乙型肝炎病毒相关肝细胞癌的诊断评估:一项大规模、多中心研究
PLoS One. 2016 Apr 12;11(4):e0153227. doi: 10.1371/journal.pone.0153227. eCollection 2016.